Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-09-29FDA Approved: ZONISAMIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for zonisamide submitted by Aurobindo Pharma Limited. It indicates regulatory approval for chang…
-
FDA approval · 2010-09-21FDA Approved: LEVETIRACETAM — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for levetiracetam under an ANDA filed by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2010-09-21FDA Approved: LEVETIRACETAM — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental abbreviated new drug application for Levetiracetam from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2010-09-21FDA Approved: LEVETIRACETAM — Supplemental Application (Patrin Pharma, Inc.)
FDA approved a supplemental application for levetiracetam from Patrin Pharma, Inc., issuing approval for their generic product under ANDA078…
-
FDA approval · 2010-09-14FDA Approved: ZARONTIN — Supplemental Application (Parke-Davis Div of Pfizer Inc)
The FDA approved a supplemental application for Zarontin (ethosuximide) submitted by Parke-Davis Div of Pfizer Inc. The approval relates to …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2010-09-10FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for divalproex sodium submitted by Mylan Pharmaceuticals Inc., resulting in a labeling update.
-
CLINICAL_TRIALS trial_result · 2010-08-26Clinical Trial Update: Study of an External Responsive Neurostimulator System on Epileptiform Activity [Phase 2]
Phase 2 study of the External Responsive Neurostimulator System for epilepsy has completed.
-
FDA approval · 2010-08-13FDA Approved: TOPIRAMATE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Topiramate from Zydus Lifesciences Limited, indicating an update to the generic's labeling post-…
-
FDA approval · 2010-08-11FDA Approved: ZONISAMIDE — Supplemental Application (Viona Pharmaceuticals Inc)
The FDA approved a supplemental application for zonisamide from Viona Pharmaceuticals Inc.
-
CLINICAL_TRIALS research · 2010-07-30Clinical Trial Update: Exploration of Genotype Based Personalized Prescription of Valproate Sodium in Anti-epileptic Treatment
This clinical trial is investigating genotype-based personalized dosing of valproate sodium for epilepsy to optimize efficacy and reduce adv…
-
FDA approval · 2010-07-28FDA Approved: LAMOTRIGINE KIT — Supplemental Application (OWP Pharmaceuticals, Inc.)
FDA approved a supplemental application for Lamotrigine Kit from OWP Pharmaceuticals, Inc., indicating regulatory action on the lamotrigine …
-
FDA approval · 2010-07-28FDA Approved: LAMOTRIGINE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Glenmark's generic lamotrigine product. The approval confirms the generic's labeling and regulat…
-
FDA approval · 2010-07-28FDA Approved: LAMOTRIGINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for lamotrigine from Aurobindo Pharma Limited.
-
FDA approval · 2010-07-28FDA Approved: LEVETIRACETAM — Original Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals LLC's original application for levetiracetam (generic).
-
CLINICAL_TRIALS trial_result · 2010-07-09Clinical Trial Update: Tolerability and Efficacy of Depakote-extended Release in the Elderly [NA]
A completed clinical trial evaluating tolerability and efficacy of Depakote extended-release in elderly patients with epilepsy/seizures.
-
FDA approval · 2010-06-29FDA Approved: OXCARBAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for oxcarbazepine submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2010-06-29FDA Approved: OXCARBAZEPINE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for oxcarbazepine by ANI Pharmaceuticals, Inc., updating regulatory approvals for this product.
-
FDA other · 2010-06-29FDA Approved: OXCARBAZEPINE — Supplemental Application (Breckenridge Pharmaceutical, Inc.)
The FDA approved a supplemental application for oxcarbazepine submitted by Breckenridge Pharmaceutical, Inc.
-
FDA approval · 2010-06-27FDA Approved: CLONAZEPAM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for clonazepam submitted by Teva Pharmaceuticals USA, Inc., marking an updated regulatory action for…
-
CLINICAL_TRIALS trial_result · 2010-06-24Clinical Trial Update: Non-Interventional Study With LYRICA (Pregabalin) In Patients With Epilepsy As Adjunctive Therapy Of Partial Seizures To Reduce Seizure Frequency
A completed non-interventional study evaluating pregabalin (LYRICA) as adjunctive therapy for partial seizures in epilepsy; results posted i…
-
FDA approval · 2010-06-23FDA Approved: LEVETIRACETAM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for LEVETIRACETAM from Torrent Pharmaceuticals Limited, enabling a generic version of the anti-seizu…
-
FDA approval · 2010-06-23FDA Approved: LAMOTRIGINE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for lamotrigine from Zydus Pharmaceuticals USA Inc., granting approval for changes to the alread…
-
FDA approval · 2010-06-15FDA Approved: LORAZEPAM — Original Application (Pharmaceutical Associates, Inc.)
FDA approved Lorazepam under an Original Application for an ANDA held by Pharmaceutical Associates, Inc., establishing a generic version of …
-
FDA approval · 2010-05-31FDA Approved: ZONISAMIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical's supplemental application for Zonisamide (zonisamide), indicating an update to the approved product.
-
FDA approval · 2010-05-28FDA Approved: VALPROIC ACID — Original Application (QUAGEN PHARMACEUTICALS LLC)
The FDA approved a generic version of valproic acid from Quagen Pharmaceuticals LLC under an Original Abbreviated New Drug Application.